Will Rigetti's FY2026 total revenue exceed $20M?
Current Prediction
Why This Question Matters
Revenue trajectory is the most tangible measure of commercial progress. Announced orders ($14.1M from C-DAC and Novera alone) suggest $20M+ is achievable, which would represent 125%+ YoY growth from the $8.9M base. Exceeding $20M would validate the on-premises system sales strategy and partially address the MIXED capital deployment signal. Falling short would indicate that announced orders are not converting to recognized revenue, raising execution questions despite the strong balance sheet.
Prediction Distribution
Individual Predictions(9 runs)
Announced orders for 2026 total approximately $14.1M+ (C-DAC $8.4M + Novera $5.7M), plus AFRL ratable (~$1.9M/yr), Japanese research org QPU (undisclosed), and 'a few more in the pipeline.' Total announced pipeline exceeds $16M. Reaching $20M requires approximately $4M in additional orders or pipeline conversion. The question is whether revenue recognition happens within FY2026 or slips to 2027. The biggest risk is C-DAC delivery timing — if the $8.4M recognizes in Q1 2027 instead of Q4 2026, the target may be missed. Point-in-time rev rec on complex system validation creates timing uncertainty. I estimate 62% based on announced pipeline exceeding $16M but discounted for rev rec timing risk.
The $20M threshold requires delivering on announced orders AND recognizing revenue within the calendar year. The Novera systems ($5.7M, Q1-Q2 delivery) are more straightforward — smaller systems with simpler validation. The C-DAC system ($8.4M) is the critical path item: if 108Q deployment succeeds and C-DAC delivery/validation completes by December 2026, revenue likely exceeds $20M. If C-DAC slips to 2027, revenue depends on pipeline conversion for the remaining gap. The AFRL ratable ($1.9M) is reliable. Without C-DAC, the floor is approximately $7.6M from Novera + AFRL, requiring $12.4M+ from other sources — which is possible but less certain. With C-DAC, the floor is $16M+ from known orders.
Revenue recognition math: Novera 2x ($5.7M, Q1-Q2) + AFRL ratable (~$1.9M) + Japanese QPU (est. $0.5-1.5M, Q2) + cloud/misc (~$1-2M) = $9.1-11.1M base without C-DAC. Adding C-DAC ($8.4M, H2) brings total to $17.5-19.5M. The gap to $20M is small but depends on additional pipeline conversion or C-DAC timing. CEO mentioned 'a few more [Novera orders] in the pipeline,' suggesting 1-2 more orders. If even one additional Novera system ($2-3M) closes, $20M is achievable even with modest C-DAC timing slip. I estimate 60% — the pipeline is strong but execution risk on multiple simultaneous deliveries is real.
The announced order pipeline is strong relative to the $20M target, but Rigetti has demonstrated revenue decline for two consecutive years despite growing cash and partnerships. Revenue recognition is lumpy and depends on complex system delivery validation. The C-DAC system ($8.4M) is the largest single item and depends on 108Q readiness, international logistics, and on-site validation — any of which could push to 2027. Without C-DAC revenue in FY2026, the target requires significant unannounced order conversion. I lean slightly above 50% because the pipeline is visible, but discount for execution risk on a company with a pattern of timeline slippage.
The math works if C-DAC delivers: $5.7M Novera + $8.4M C-DAC + $1.9M AFRL + $1-3M misc = $17-19M from known sources, plus unannounced pipeline. The question is really 'will C-DAC revenue be recognized in FY2026?' Given H2 2026 target and the 108Q deployment imminent, there is roughly 6-9 months for C-DAC production, shipping, installation, and validation. That timeline is tight but feasible. If 108Q deployment succeeds on time, C-DAC production can begin. Revenue exceeding $20M is more likely than not but with meaningful risk.
Low confidence because this market hinges on C-DAC delivery timing. The revenue math without C-DAC gets to maybe $11-13M — well short. With C-DAC, it gets to $19-21M — right at the threshold. So the question collapses to: will C-DAC complete validation in FY2026? I estimate that at roughly 50-55%, factoring in international logistics complexity and the sequential dependency on 108Q deployment. Additional pipeline conversion provides some buffer. Near coin-flip on the $20M specific threshold.
Announced orders ($14.1M+) exceed FY2025 revenue ($8.9M) and approach $20M with ratable contracts. C-DAC ($8.4M) is the swing factor. Pipeline mentions suggest additional orders. Point-in-time rev rec is the key risk. Slightly above 50% — pipeline supports it but execution risk is real.
Coin-flip assessment. The $20M target requires C-DAC rev rec in FY2026. Without it, gap is too large. C-DAC delivery depends on 108Q success and international logistics — both have slippage risk. With C-DAC, additional pipeline could push above $20M. Without it, falls short at ~$11-13M.
Revenue pipeline is visible and strong vs FY2025 base. The $20M threshold is achievable with C-DAC plus known orders. Slight lean toward YES based on pipeline strength, but C-DAC timing risk and point-in-time rev rec uncertainty keep this close to 50%.
Resolution Criteria
Resolves YES if Rigetti's total revenue for the fiscal year ending December 31, 2026, as reported in annual earnings or 10-K filing, equals or exceeds $20M. Resolves NO if reported FY2026 revenue is below $20M.
Resolution Source
Rigetti 10-K filing or Q4 2026 earnings call
Source Trigger
2026 Revenue Trajectory — Announced orders suggest $20-25M+ is achievable vs $8.9M in FY2025. Tracking actual revenue recognition against announced orders validates the sales pipeline.
Full multi-lens equity analysis